| Variable |
No. |
% |
| 1) Age at Time of Diagnosis: |
|
|
| Range |
28 - 69 years. |
|
| Median |
48 years. |
|
| 2) Laterality: |
|
|
| RT Side |
26 |
48.1% |
| LT Side |
28 |
51.9% |
| 3) Quadrant Site |
|
|
| UO (Upper Outer) |
26 |
48.1% |
| UI (Upper Inner) |
7 |
13% |
| LO (Lower Outer) |
11 |
20.4% |
| LI (Lower Inner) |
6 |
11.1% |
| CE (Central) |
4 |
7.4% |
| 4) Tumor Grade |
|
|
| Grade 1 |
2 |
3.7% |
| Grade 2 |
43 |
79.6% |
| Grade 3 |
9 |
16.7% |
| 5) Tumor Histopathology |
|
|
| IDC (Infiltrating Ductal Carcinoma) |
52 |
96.3% |
| ILC (Infiltrating Lobular Carcinoma) |
2 |
3.7% |
| 6) T Stage: |
|
|
| T1 |
14 |
26% |
| T2 |
40
|
74% |
| 7) Node Stage: |
|
|
| N0 |
22 |
40.7% |
| N1 |
32 |
59.3 % |
| 8) Hormonal Receptors: |
|
|
| Positive ER and/or PR |
39 |
72.22% |
| Negative ER and/or PR |
15 |
27.78% |
| 9) Her 2 New Over-Expression: |
|
|
| No |
44 |
81.5% |
| Yes |
10 |
18.5% |